Rybelsus stands out as the first oral GLP-1 receptor agonist specifically designed to help manage diabetes, and it has captured attention for its innovative approach. This medication works by mimicking the action of incretin hormones, which play a crucial role in glucose regulation. After a meal, incretins release in response…